These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3114550)

  • 1. [Recombinant (IFN-alpha 2b) therapy in hairy cell leukemia].
    Schwarzmeier JD; Wagner L; Prischl F; Schwabe M; Lion T; Micksche M; Köller U; Bernhart M; Fritz O; Seewann HL
    Klin Wochenschr; 1987 Jul; 65(14):699-705. PubMed ID: 3114550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon alpha-2 for hairy cell leukemia: evidence for induction of RNA synthesis in hairy cells and failure to correlate enhancement of natural killer cells with elimination of hairy cells.
    Schwarzmeier JD; Schwabe M; Prischl F; Wagner L; Lion T; Micksche M; Köller U
    Eur J Haematol; 1987 Nov; 39(5):418-25. PubMed ID: 3691760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effectiveness of gamma interferon and alpha interferon in hairy cell leukemia].
    Niederle N; Doberauer C; Kloke O; Höffken K; Schmidt CG
    Klin Wochenschr; 1987 Jul; 65(14):706-12. PubMed ID: 3114551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b.
    Glaspy JA; Souza L; Scates S; Narachi M; Blatt L; Ambersley J; Golde DW
    J Immunother (1991); 1992 Apr; 11(3):198-208. PubMed ID: 1381218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant interferon-alpha-2b treatment of hairy-cell leukaemia: experience with a low-dose schedule.
    Hasselbalch H; Braide I; Lisse I; Röckert LL; Swolin B; Carneskog J; Hagberg H; Hippe E; Jensen MK; Lundin P
    Eur J Haematol; 1988 Nov; 41(5):438-44. PubMed ID: 3061836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The dose of alpha interferon in induction and maintainance therapy of hairy cell leukemia].
    Kloke O; May D; Wandl U; Niederle N
    Onkologie; 1988; 11 Suppl 2():41-5. PubMed ID: 3065687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relapse after interferon alfa-2b therapy for hairy-cell leukemia: analysis of prognostic variables.
    Ratain MJ; Golomb HM; Vardiman JW; Westbrook CA; Barker C; Hooberman A; Bitter MA; Daly K
    J Clin Oncol; 1988 Nov; 6(11):1714-21. PubMed ID: 3054003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Beta interferon therapy in hairy cell leukemia].
    von Wussow P; Dühlmann J; Grethlein T; Hirschmann WD; Hügl E; Koch O; Martin WR; Pees HW; Urbanitz W; Freund M
    Klin Wochenschr; 1987 Jul; 65(14):688-90. PubMed ID: 3306139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mid-term observations on the efficacy of alpha-interferon in hairy cell leukemia and status of the interferon system of patients in remission.
    Quesada JR; Lepe-Zuniga JL; Gutterman JU
    Leukemia; 1987 Apr; 1(4):317-9. PubMed ID: 3669753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Very low dose alpha-2b interferon for the treatment of hairy cell leukemia.
    Thompson JA; Kidd P; Rubin E; Fefer A
    Blood; 1989 May; 73(6):1440-3. PubMed ID: 2713488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results of alpha interferon as initial therapy and splenectomy as consolidation therapy in patients with hairy cell leukemia. Final report from the Italian Cooperative Group for HCL.
    Federico M; Frassoldati A; Lamparelli T; Foà R; Brugiatelli M; Annino L; Baldini L; Capnist G; Chisesi T; di Celle PF
    Ann Oncol; 1994 Oct; 5(8):725-31. PubMed ID: 7826905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized study of the duration of treatment with interferon alfa-2B in patients with hairy cell leukemia.
    Golomb HM; Ratain MJ; Fefer A; Thompson J; Golde DW; Ozer H; Portlock C; Silber R; Rappeport J; Bonnem E
    J Natl Cancer Inst; 1988 May; 80(5):369-73. PubMed ID: 3282078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Primary treatment of hairy cell leukemia with low-dose human recombinant interferon-alpha-2c (Hr-IFn alpha 2c) in comparison with therapy following splenectomy. Interferon (IFn-alpha 2c) in HCL before or after splenectomy].
    Pralle H; Zwingers T; Boedewadt S; Bross K; Dörken B; Gamm H; Ho AD; Parwaresch RM; Schmitz N; Papendick U
    Onkologie; 1987 Feb; 10(1):5-10. PubMed ID: 3295625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of clinical efficacy and toxicity of conventional and optimum biological response modifying doses of interferon alpha-2C in the treatment of hairy cell leukemia: a retrospective analysis of 39 patients.
    Gastl G; Werter M; De Pauw B; Nerl C; Aulitzky W; von Lüttichau I; Tilg H; Thaler J; Lang A; Abbrederis K
    Leukemia; 1989 Jun; 3(6):453-60. PubMed ID: 2725061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Splenectomy following complete response to alpha interferon (IFN) therapy in patients with hairy cell leukemia (HCL): results of the HCL88 protocol. Italian Cooperative Group for the Study of Hairy Cell Leukemia (ICGHCL).
    Damasio EE; Frassoldati A
    Leuk Lymphoma; 1994; 14 Suppl 1():95-8. PubMed ID: 7820061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid improvement in a terminal case of hairy cell leukemia treated with a new human recombinant interferon, IFN-alpha-C.
    Aderka D; Levo Y; Rahmani R; Mory Y; Vaks B; Horowitz O; Doerner T; Shoham J; Wallach D; Revel M
    Isr J Med Sci; 1985 Dec; 21(12):977-81. PubMed ID: 4093298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant alpha-2b-interferon in therapy of previously untreated hairy cell leukemia: long-term follow-up results of study by Cancer and Leukemia Group B.
    Rai KR; Davey F; Peterson B; Schiffer C; Silver RT; Ozer H; Golomb H; Bloomfield CD
    Leukemia; 1995 Jul; 9(7):1116-20. PubMed ID: 7630181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural IFN-alpha therapy in hairy-cell leukaemia (namalva-type IFN--Wellferon).
    Worman CP; Nethersell AB; Bottomley JM; Apostolov K; Barker W; Cawley JC
    Klin Wochenschr; 1987 Jul; 65(14):685-7. PubMed ID: 3306138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The alpha 2 (r) interferon in the treatment of hairy cell leukemia: progressive report of 25 cases.
    Mandelli F; Cafolla A; Annino L; Amadori S; Gentile A; Bianco P; Dianzani F
    J Biol Regul Homeost Agents; 1987; 1(4):177-82. PubMed ID: 3332545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of hairy cell leukemia with recombinant alpha interferon: II. In vivo down-regulation of alpha interferon receptors on tumor cells.
    Billard C; Sigaux F; Castaigne S; Valensi F; Flandrin G; Degos L; Falcoff E; Aguet M
    Blood; 1986 Mar; 67(3):821-6. PubMed ID: 2936410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.